Clinical Trials Browser

INDUSTRY × lucatumumab × Lymphoid × Clear all

NCT00670592 2020-12-17

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Phase 1/2 Completed

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT01275209 2020-12-08

LIFT

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00108108 2012-10-01

Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Leukemia, Lymphocytic, Chronic, B-Cell